Showing results (31-40 of 116) with videos related to

Sort By:
Pageof 12
Blood Advances|March 12, 2021
Unmarried or less-educated patients with mantle cell lymphoma are less likely to undergo a transplant, leading to lower survivalIngrid Glimelius, Karin E Smedby, Alexandra Albertsson-Lindblad, et al.
British Journal of Haematology|February 18, 2020
Trends in the prevalence, incidence and survival of non-Hodgkin lymphoma subtypes during the 21st century - a Swedish lymphoma register studySara Ekberg, Karin E Smedby, Ingrid Glimelius, et al.
Journal of Cancer Survivorship : Research and Practice|November 14, 2015
Lost workdays in uterine cervical cancer survivors compared to the general population: impact of treatment and relapseÅsa H Everhov, Sara Ekberg, Angelica Lindén Hirschberg, et al.
British Journal of Haematology|November 25, 2020
Clinical characteristics and outcomes among 2347 patients aged ≥85 years with major lymphoma subtypes: a Nordic Lymphoma Group studyTove Wästerlid, Kim Oren Gradel, Sandra Eloranta, et al.
European Journal of Cancer (Oxford, England : 1990)|November 12, 2023
Secondary malignancies among mantle cell lymphoma patientsKossi D Abalo, Karin E Smedby, Sara Ekberg, et al.
Acta Oncologica (Stockholm, Sweden)|November 24, 2025
Utilisation of healthcare in children born to lymphoma survivors in SwedenJoshua P Entrop, Viktor Wintzell, Caroline E Dietrich, et al.
Journal of the National Cancer Institute|January 17, 2025
Mortality after cancer diagnosis among children with congenital heart disease in Denmark and SwedenChristina-Evmorfia Kampitsi, Line Kenborg, Hanna Mogensen, et al.
Journal of Cancer Survivorship : Research and Practice|February 5, 2024
Long-term prescribed drug use in stage I-III rectal cancer patients in Sweden, with a focus on bowel-regulating drugs after surgical and oncological treatmentSol Erika Boman, Stina Fuentes, Caroline Nordenvall, et al.
American Journal of Hematology|September 9, 2015
Long-term survival in young and middle-aged Hodgkin lymphoma patients in Sweden 1992-2009-trends in cure proportions by clinical characteristicsIngrid Glimelius, Sara Ekberg, Mats Jerkeman, et al.
British Journal of Haematology|May 5, 2021
Age is the most important predictor of survival in diffuse large B-cell lymphoma patients achieving event-free survival at 24 months: a Swedish population-based studyAmal Abu Sabaa, Charlott Mörth, Sverker Hasselblom, et al.
Pageof 12